TELLYHealth
OtherEducational videos and questions.
NCT Number: NCT02839759
This RCT will have two arms: A control group that receives the standard of care from audiologists and an experimental group that receives both the standard of care and the at-home use of the TELLYHealth intervention. Subjects in each group will complete questionnaires at enrollment, mid-study and at the end of the study.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Clear Sound Audiology, Gainesville, Florida, United States
HTM will develop the "TELLYHealth (tm) system" that will provide education on hearing aid use and maintenance. HTM will conduct a randomized controlled trial (RCT) to quantify the benefits of TELLYHealth to patients and audiologists including: reductions in hearing handicap, improved knowledge of hearing aid handling, use and communications strategies; and improved audiologist aftercare. The investigators will recruit 80 subjects (half in each group) and each subject will participate in the study for 8-12 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Educational videos and questions.
Time frame: 8-12 weeks
Pre-post changes in the HHIE total scores
Time frame: 8-12 weeks
Pre-post changes in the CSOA communication strategies & attitudes scores
Healthcare Technologies and Methods, LLC
Industry
Interactive Technology for Hearing Aid Education and Acceptance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02729402
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT05190081
Age Related Hearing Loss, Ear Diseases
Denizli, Kinikli, Turkey (Türkiye)
View Trial DetailsNCT02448706
Ear Diseases, Hearing Disorders
Boulder, Colorado, United States
View Trial Details